Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2169565308;65309;65310 chr2:178584468;178584467;178584466chr2:179449195;179449194;179449193
N2AB2005460385;60386;60387 chr2:178584468;178584467;178584466chr2:179449195;179449194;179449193
N2A1912757604;57605;57606 chr2:178584468;178584467;178584466chr2:179449195;179449194;179449193
N2B1263038113;38114;38115 chr2:178584468;178584467;178584466chr2:179449195;179449194;179449193
Novex-11275538488;38489;38490 chr2:178584468;178584467;178584466chr2:179449195;179449194;179449193
Novex-21282238689;38690;38691 chr2:178584468;178584467;178584466chr2:179449195;179449194;179449193
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTG
  • RefSeq wild type template codon: GAC
  • Domain: Fn3-45
  • Domain position: 37
  • Structural Position: 39
  • Q(SASA): 0.1958
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/R rs1174402887 -1.559 0.989 N 0.632 0.3 0.729612430995 gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 0 None 3.27E-05 None 0 0 0
L/R rs1174402887 -1.559 0.989 N 0.632 0.3 0.729612430995 gnomAD-4.0.0 1.59233E-06 None None None None N None 0 0 None 0 0 None 0 0 0 1.43299E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.2543 likely_benign 0.2271 benign -2.297 Highly Destabilizing 0.525 D 0.593 neutral None None None None N
L/C 0.3745 ambiguous 0.3601 ambiguous -1.351 Destabilizing 0.016 N 0.493 neutral None None None None N
L/D 0.7641 likely_pathogenic 0.7455 pathogenic -2.512 Highly Destabilizing 0.991 D 0.652 neutral None None None None N
L/E 0.4061 ambiguous 0.3815 ambiguous -2.291 Highly Destabilizing 0.974 D 0.66 neutral None None None None N
L/F 0.1082 likely_benign 0.1005 benign -1.308 Destabilizing 0.037 N 0.48 neutral None None None None N
L/G 0.6195 likely_pathogenic 0.5959 pathogenic -2.817 Highly Destabilizing 0.974 D 0.659 neutral None None None None N
L/H 0.136 likely_benign 0.1365 benign -2.313 Highly Destabilizing 0.998 D 0.673 neutral None None None None N
L/I 0.0823 likely_benign 0.0765 benign -0.798 Destabilizing 0.067 N 0.479 neutral None None None None N
L/K 0.2791 likely_benign 0.286 benign -1.685 Destabilizing 0.974 D 0.631 neutral None None None None N
L/M 0.0917 likely_benign 0.09 benign -0.69 Destabilizing 0.966 D 0.661 neutral N 0.463628384 None None N
L/N 0.3462 ambiguous 0.3262 benign -1.991 Destabilizing 0.991 D 0.671 neutral None None None None N
L/P 0.969 likely_pathogenic 0.9694 pathogenic -1.279 Destabilizing 0.989 D 0.673 neutral D 0.522713973 None None N
L/Q 0.1238 likely_benign 0.12 benign -1.852 Destabilizing 0.989 D 0.623 neutral N 0.456507623 None None N
L/R 0.187 likely_benign 0.187 benign -1.432 Destabilizing 0.989 D 0.632 neutral N 0.43536156 None None N
L/S 0.2843 likely_benign 0.2564 benign -2.647 Highly Destabilizing 0.915 D 0.625 neutral None None None None N
L/T 0.1894 likely_benign 0.1672 benign -2.294 Highly Destabilizing 0.842 D 0.616 neutral None None None None N
L/V 0.0786 likely_benign 0.073 benign -1.279 Destabilizing 0.012 N 0.391 neutral N 0.406292234 None None N
L/W 0.2427 likely_benign 0.2526 benign -1.732 Destabilizing 0.998 D 0.64 neutral None None None None N
L/Y 0.2327 likely_benign 0.2377 benign -1.414 Destabilizing 0.904 D 0.651 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.